HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • The ‘price’ of value-based care
  • The Evolving Physician Advisor: From UM to Value-Based Care & AI
  • CMMI Announces Make America Healthy Again Strategy, Prioritizes Choice For Care Settings, Including In Homes
  • RECORDED WEBINAR: Best Value-Based Care Strategies PT 2: Controlling Specialty Patient Care Costs and Total Costs for Negotiating Leverage
  • A More Holistic Approach To Measurement For Value-Based Care
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us